Aceglatone, an antineoplastic agent, is a beta-glucuronidase inhibitor. Aceglatone is a compound that inhibits colon carcinogenesis and prevents the induction of colon cancer by inhibiting the hydrolysis of glucuronides. Aceglatone reduces cell proliferation, induces apoptosis and inhibits DNA synthesis in human colon cancer cells[1].
Molecular Weight:
258.18
CAS Number:
[642-83-1]
Formula:
C10H10O8
Target:
Apoptosis,DNA/RNA Synthesis,beta-glucuronidase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
